Sponsor

Dermaliq Therapeutics Inc.

United States 1201 North Market Street Suite 111, 19801-1156, United States

About the sponsor

Dermaliq Therapeutics Inc. focuses on clinical research in atopic dermatitis, with interest in conditions marked by chronic skin inflammation, barrier disruption, and itch-related symptoms.

Atopic eczema
Inflammatory dermatoses
Skin barrier dysfunction

The sponsor’s research activity is centered on therapeutic areas relevant to eczema care and cutaneous wound healing in affected patients.

About Specializations

Dermaliq Therapeutics Inc. runs clinical trials in conditions such as Dermatitis atopic, among others.

Dermatitis atopic

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Dermatitis atopic

Not recruiting

Registered drug

Safety and Tolerability of Topical Iodine (DLQ03) in Patients with Mild to Moderate Atopic Dermatitis Colonized with Staphylococcus aureus

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Dermaliq Therapeutics Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →